Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions

Ref ID 141
First Author M. J. Page
Journal THE COCHRANE LIBRARY
Year Of Publishing 2014
URL https://pubmed.ncbi.nlm.nih.gov/25271098/
Keywords • General medical
• Protocols
• Pre-specification
• Cochrane
• Multiplicity
Problem(s) • Multiplicity of outcomes and lack of pre-specification for outcome reporting
• Undocumented or unjustified deviations to the review protocol
Article Type Empirical
Article Subtype Meta-epidemiological analysis
First Author Country Australia
Aim To assess the results of empirical studies that have investigated the prevalence of selective inclusion or reporting in systematic reviews of randomised controlled trials, and investigated the factors (e.g. statistical significance or direction of effect) associated with the prevalence and quantified the bias indexed across several databases up to May 2013.
Level of Investigation Analytical
Summary of Findings Based on a meta-analysis of four of the seven included studies (which included 485 Cochrane Reviews), 38% (95% confidence interval (CI) 23% to 54%) of systematic reviews added, omitted, upgraded or downgraded at least one outcome between the protocol and published systematic review. The association between statistical significance and discrepant outcome reporting between protocol and published systematic review was uncertain. The meta-analytic estimate suggested an increased risk of adding or upgrading (i.e. changing a secondary outcome to primary) when the outcome was statistically significant, although the 95%CI included no association and a decreased risk as plausible estimates (RR 1.43, 95% CI 0.71 to 2.85; two studies, n = 552 meta-analyses). Also, the meta-analytic estimate suggested an increased risk of downgrading (i.e. changing a primary outcome to secondary) when the outcome was statistically significant, although the 95% CI included no association and a decreased risk as plausible estimates (RR 1.26, 95% CI 0.60 to 2.62; two studies, n = 484 meta-analyses).
Number of systematic reviews included 485
Number of eligible systematic reviews assessed 4460
Treatment impacted Yes
Treatment impacted description
Interpretation impacted Yes
Interpretation impacted description The meta-analytic estimate suggested an increased risk of adding or upgrading (i.e. changing a secondary outcome to primary) when the outcome was statistically significant, although the 95%CI included no association and a decreased risk as plausible estimates (RR 1.43, 95% CI 0.71 to 2.85; two studies, n = 552 meta-analyses).